CTRI/2018/03/012587
Completed
未知
Evaluation of the efficacy and tolerance of the 2 test products (Body Sanitizers), in men for axillary malodour
IPI India Pvt Ltd0 sites35 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- IPI India Pvt Ltd
- Enrollment
- 35
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants with shaved underarms 2 days prior to the beginning of the study.
- •Participants with similar and moderate axillary odour.
- •Participants willing to abstain from alcohol, garlic and methi for 24 hours before each visit.
Exclusion Criteria
- •People who have a job involving water contact or a job which causes perspiration.
- •Participants with rashes, cuts or skin blemishes on test site.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Phase II study of the tolerability and efficacy of the histone deacetylase inhibitor sodium valproate administered in conjunction with 5-azacitidine, theophylline and all trans-retinoic acid in patients with acute myeloid leukaemia and high risk myelodysplasiaAcute myeloid leukaemia or high risk myelodysplasiaCancerLeukamiaISRCTN68418952niversity of Birmingham (UK)20
Active, not recruiting
Phase 1
Phase II Study of the Tolerability and Efficacy of the Histone Deacetylase Inhibitor Sodium Valproate given in Conjunction with 5-azacytidine and ATRA (all trans retinoic acid ) in Patients with Acute Myeloid Leukaemia. - Val/AzaEUCTR2005-000550-75-GBniversity of Birmingham80
Active, not recruiting
Phase 1
Investigation of efficacy and tolerability of the healing water Staatl. Fachingen STILL in patients for symptomatic treatment of heartburn in comparison to placeboEfficacy and tolerability investigations of a healing water in symptomatic treatment of heartburnMedDRA version: 20.0Level: LLTClassification code 10019326Term: HeartburnSystem Organ Class: 100000004856Therapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2017-001100-30-DEFachingen Heil- und Mineralbrunnen GmbH150
Recruiting
Phase 3
Investigation of efficacy and tolerability of the healing water Staatl. Fachingen STILL in patients for symptomatic treatment of heartburn in comparison to placeboMedDRA - Heartburn 10019326R12HeartburnDRKS00016696Fachingen Heil- und Mineralbrunnen GmbH150
Completed
Not Applicable
To study the effect and safety of an Anti-acne creamCTRI/2022/09/045553PhytoMyco Research Pvt Ltd33